News | July 07, 2023
Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
The company is already marketing the 4 mg and 10 mg strengths
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Subscribe To Our Newsletter & Stay Updated
